MedTrace Logo

Sevoflurane Versus Propofol; Neuro Endocrine Response in Patients of Oociyt Pick up

NCT03507621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-12-24

No results posted yet for this study

Summary

Patients in the study will be grouped as 1st group Propofol, 2nd Group Sevofluran.Preoperative blood will be taken from the patients and cortisol, acth, glucagon, aldosterone, PGE2, CRH will be studied. During the operation, the patient's systolic blood pressure, diastolic blood pressure, mean arterial pressure, heart rate, oxygen saturation will be followed. Analgesia will be provided according to the body movements of the patient and VAS measurement will be performed. The patient's pain will be assessed by the VAS (Visuel Analogue Scale) scoring system and during the first hour postoperatively after the patient's consciousness is complete . Hormones such as cortisol, acth, glucagon, aldosterone, PGE2, CRH will be studied biochemically in the follicular fluid and blood of the patient postoperatively. The aim of in the study is to compare the effect of propofol and sevoflurane routinely applied in IVF centers on postoperative pain scores and stress hormones in blood and follicular fluid in a painful and stressful application of egg collection

Conditions

  • Anesthesia
  • Infertility
  • Pain, Postoperative
  • Stress, Psychological

Sponsors & Collaborators

  • Kahramanmaras Sutcu Imam University

    collaborator OTHER

  • Yavuz Orak

    lead OTHER

Principal Investigators

  • Yavuz orak, md · Kahramanmaraş Sutcu Imam University Faculty of Medicine Kahramanmaraş/ Turkey

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-30
Primary Completion
2018-07-01
Completion
2019-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03507621 on ClinicalTrials.gov